BiVictriX Therapeutics (BVX) Insider Trading & Ownership → Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad) Free BVX Stock Alerts GBX 11.50 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades BiVictriX Therapeutics (LON:BVX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.65%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)£46,566.33Number OfInsiders Selling(Last 3 Years)0 Get BVX Insider Trade Alerts Want to know when executives and insiders are buying or selling BiVictriX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BVX Insider Buying and Selling by Quarter Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here BiVictriX Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2022Iain Gladstone RossInsiderBuy30,000GBX 18£5,4003/8/2022Iain Gladstone RossInsiderBuy100,000GBX 22£22,00012/20/2021Tiffany Jane ThornInsiderBuy25,000GBX 26£6,50011/4/2021Robert Edward HawkinsInsiderBuy20,000GBX 22£4,4009/22/2021Iain Gladstone RossInsiderBuy43,507GBX 19£8,266.33 (Data available from 1/1/2013 forward) BVX Insider Trading Activity - Frequently Asked Questions Who is on BiVictriX Therapeutics's Insider Roster? The list of insiders at BiVictriX Therapeutics includes Iain Gladstone Ross, Robert Edward Hawkins, and Tiffany Jane Thorn. Learn more on insiders at BVX. What percentage of BiVictriX Therapeutics stock is owned by insiders? 36.65% of BiVictriX Therapeutics stock is owned by insiders. Learn more on BVX's insider holdings. Which BiVictriX Therapeutics insiders have been buying company stock? The following insider purchased BVX shares in the last 24 months: Iain Gladstone Ross (£5,400). How much insider buying is happening at BiVictriX Therapeutics? Insiders have purchased a total of 30,000 BVX shares in the last 24 months for a total of £5,400 bought. More Insider Trading Tools from MarketBeat Related Companies: Roquefort Therapeutics Insider Buying Oxford Cannabinoid Technologies Insider Buying Fusion Antibodies Insider Buying Destiny Pharma Insider Buying Oncimmune Insider Buying OptiBiotix Health Insider Buying OKYO Pharma Insider Buying Oxford BioDynamics Insider Buying Sareum Insider Buying Advanced Oncotherapy Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (LON:BVX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiVictriX Therapeutics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.